RMP
ZBH icon

Richards, Merrill & Peterson’s Zimmer Biomet ZBH Stock Holding History

Richards, Merrill & Peterson’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$113K – 488
2025
Q1 		$113K Hold
1,000
– – 0.06% 179
2024
Q4 		$106K Buy
+1,000
New +$107K 0.06% 182

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Richards, Merrill & Peterson's ZBH Position: Q2 2025 in Review

Richards, Merrill & Peterson sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 1,000 shares — an estimated $113K sold.

Richards, Merrill & Peterson first reported a position in ZBH in Q4 2024 and held it in 2 quarters. The position peaked at $113K in Q1 2025. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

  • Richards, Merrill & Peterson reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
  • Richards, Merrill & Peterson sold 1,000 Zimmer Biomet shares in Q2 2025, an estimated $113K.
  • Richards, Merrill & Peterson first reported a position in Zimmer Biomet in Q4 2024 and held it in 2 quarters.
  • Richards, Merrill & Peterson's Zimmer Biomet position peaked at $113K in Q1 2025.
  • 934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2025, filed 31 Jul 2025.